about
The roles of dopamine and related compounds in reward-seeking behavior across animal phylaCalmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cellDisulphiram for alcohol dependenceAnticonvulsants for alcohol withdrawalDisulfiram for alcohol dependenceAcamprosate for alcohol dependenceGenetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findingsProbing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative reviewProteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior?Cocaine addiction in mothers: potential effects on maternal care and infant development.Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for painNicotine addictionStress, dysregulation of drug reward pathways, and the transition to drug dependenceChronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapseNeurocircuitry of addictionA role for brain stress systems in addiction.Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intakePharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependenceHow should we revise diagnostic criteria for substance use disorders in the DSM-V?Parenting Interventions for Drug-Dependent Mothers and Their Young Children: The Case for an Attachment-Based Approach*Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapiesSome rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediolDopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]The Influence of Palatable Diets in Reward System Activation: A Mini ReviewNeuroimmune Function and the Consequences of Alcohol ExposureUltrasonic Vocalizations as a Measure of Affect in Preclinical Models of Drug Abuse: A Review of Current FindingsSerotonergic gene variation in substance use pharmacotherapy: a systematic reviewRevisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behaviorPresynaptic dopamine modulation by stimulant self-administrationThe downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathwaysRole of cues and contexts on drug-seeking behaviourObesity and addiction: neurobiological overlapsExercise and Alcohol Consumption: What We Know, What We Need to Know, and Why it is ImportantA computational hypothesis for allostasis: delineation of substance dependence, conventional therapies, and alternative treatmentsPositron emission tomography molecular imaging of dopaminergic system in drug addictionThe relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humansTreatment approaches for interoceptive dysfunctions in drug addictionMultiple roles for orexin/hypocretin in addictionThe comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism
P2860
Q21131055-D1540929-2386-4DCB-A4DF-2BF981AE14B2Q22254626-B64D6AFB-EF72-4610-9C61-A6000CB28F7BQ24236369-717BCBDF-3029-4836-878C-805AE9343955Q24236686-3C4CBC96-C2B7-4136-8BCE-18337A245DFFQ24242348-2B086AEE-DF39-4368-A0AC-21088DF67D62Q24248164-93C28451-3AF2-4A41-90A3-5356D6EF03BCQ24289498-59845775-5F46-4174-8E36-F65C6C675D95Q24602117-2A916C16-427C-4C4C-AC7B-0C4B662E3DD5Q24603107-B0DE6160-E255-4C6A-B563-9822BACA6C41Q24604696-4C37D3D2-2993-48A7-AB89-CAA7DD926474Q24605135-51A52051-F1EE-433C-A2B2-96397A239664Q24626554-81410DC3-0837-4C3F-A7B2-B2F789223969Q24629577-F46D4548-4029-44DA-92CF-3396B9D7AB90Q24633835-3C5C4B1C-4128-473B-A52A-EC6BBA58AD03Q24647156-EC9620EA-D6DE-4FF9-BA13-2FBB2D8F02E2Q24649537-C1E5DC1C-0AEF-4F64-9E43-255CF11010C6Q24651508-562FA7B4-F143-4C82-8C04-F3F1A9F2D831Q24658266-9BB2BB8D-D14E-4F1E-AB29-490BF60EB0E6Q24658318-275C208D-323E-4266-B4AF-E67935F71884Q24670165-FDBE9959-E6A4-4FAB-829C-AC6212E48958Q24672819-25B6AF40-445D-439B-B50B-A639DD083723Q24679317-042E161D-0E7F-4FE6-BDFD-9758F79CCC99Q24681363-5FCE18EE-904A-40B2-A35C-3BBCB123F4C3Q24799720-CB530DC8-7B46-4293-9B98-7D40B9E9473FQ26752942-A18EEEC7-0FCE-45D3-B30B-9052DB758FB7Q26773207-B2794C35-EE62-44C2-8DD8-1A757B01C8CFQ26786501-8F7B5341-D1BA-4DC6-A0CC-40593A43182AQ26799093-1D3D9433-1D6B-453C-8715-DC24D97D89C2Q26801102-EC42E65D-20B0-4013-B20C-29D1742D009FQ26823507-381F9C9D-D7B4-466F-847E-0405554E9D02Q26824011-3B10A532-16DD-436E-A700-C49A3DC37272Q26825476-8850CD5D-AB9D-4E1C-AF5F-77F8C701CEC5Q26827446-D3153212-E330-4F03-80E8-06D320553D33Q26858791-0944D154-989A-4F29-9EA6-BBD072CF849DQ26859813-E717EE36-8F6E-439A-B0B4-D8A8D5D094F1Q26992051-02DD026C-D48A-492B-AE9D-B1AA34B6265AQ26992207-B715FAD5-D60C-4BB7-AC30-048EB8AB6ABFQ26995601-A426CF92-B560-4B0A-8EF9-49A57F09840AQ27009536-72DEB63E-AFB8-467E-8DF5-D120B29E5337Q27024180-C88F6EC0-0DD2-4FC2-8CC6-77C16358E3FA
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Drug abuse: hedonic homeostatic dysregulation
@ast
Drug abuse: hedonic homeostatic dysregulation
@en
type
label
Drug abuse: hedonic homeostatic dysregulation
@ast
Drug abuse: hedonic homeostatic dysregulation
@en
prefLabel
Drug abuse: hedonic homeostatic dysregulation
@ast
Drug abuse: hedonic homeostatic dysregulation
@en
P2860
P3181
P1433
P1476
Drug abuse: hedonic homeostatic dysregulation
@en
P2093
P2860
P3181
P356
10.1126/SCIENCE.278.5335.52
P407
P577
1997-10-03T00:00:00Z